Delivery of Euthyroid Baby following Hyperthyroidism in Twin Gestation with Coexisting Complete Hydatidiform Mole.
Journal
Case reports in endocrinology
ISSN: 2090-6501
Titre abrégé: Case Rep Endocrinol
Pays: United States
ID NLM: 101576457
Informations de publication
Date de publication:
2019
2019
Historique:
received:
15
09
2019
accepted:
13
12
2019
entrez:
18
1
2020
pubmed:
18
1
2020
medline:
18
1
2020
Statut:
epublish
Résumé
Gestational trophoblastic disease (GTD) is a rare complication of pregnancy, ranging from molar pregnancy to choriocarcinoma. Twin pregnancies with GTD and coexisting normal fetus are extremely rare with an estimated incidence of 1 case per 22,000-100,000 pregnancies. Molecular mimicry between human chorionic gonadotrophin (hCG) and thyroid-stimulating hormone (TSH) leads to gestational trophoblastic hyperthyroidism (GTH) which is further associated with increased maternal and fetal complications. This is the first reported case in literature describing the delivery of a baby with biochemical euthyroid status following a twin pregnancy with hydatidiform mole (HM) associated with gestational trophoblastic hyperthyroidism (GTH). A 24-year-old G4 P3 Caucasian female with twin gestation was admitted to hospital for gestation trophoblastic hyperthyroidism. She was later diagnosed to have twin pregnancy with complete mole and coexisting normal fetus complicated by gestational trophoblastic hyperthyroidism (GTH). Despite the risk associated with the continuation of molar pregnancy, per patient request, pregnancy was continued till viability of the fetus. The patient underwent cesarean section due to worsening preeclampsia and delivered a euthyroid baby at the 24th week of gestation. Twin pregnancy with gestational trophoblastic disease and coexisting normal fetus is associated with high risk of hyperthyroidism, and careful monitoring of the thyroid function test along with dose titration of thionamides is of utmost importance throughout the gestation. If normal thyroid hormone levels are maintained during the pregnancy, euthyroidism could be successfully achieved in the baby.
Identifiants
pubmed: 31949957
doi: 10.1155/2019/2941501
pmc: PMC6944968
doi:
Types de publication
Case Reports
Langues
eng
Pagination
2941501Informations de copyright
Copyright © 2019 Rishi Raj et al.
Déclaration de conflit d'intérêts
The authors declare that they have no conflicts of interest.
Références
Taiwan J Obstet Gynecol. 2018 Aug;57(4):588-593
pubmed: 30122584
J Reprod Med. 2016 May-Jun;61(5-6):210-4
pubmed: 27424360
Lancet. 2002 Jun 22;359(9324):2165-6
pubmed: 12090984
Pathol Res Pract. 2011 Aug 15;207(8):498-504
pubmed: 21767919
Lancet Oncol. 2003 Nov;4(11):670-8
pubmed: 14602247
J Paediatr Child Health. 2007 Sep;43(9):646-8
pubmed: 17688651
Gynecol Endocrinol. 2004 May;18(5):269-77
pubmed: 15346663
Eur J Obstet Gynecol Reprod Biol. 2017 May;212:1-8
pubmed: 28301807
Best Pract Res Clin Endocrinol Metab. 2004 Jun;18(2):249-65
pubmed: 15157839
Endocr Rev. 1997 Jun;18(3):404-33
pubmed: 9183570
J Clin Diagn Res. 2017 Jul;11(7):QD01-QD02
pubmed: 28892983
Br J Cancer. 2011 May 24;104(11):1665-9
pubmed: 21522146
Lancet. 2012 Jan 14;379(9811):130-5
pubmed: 22130490
Indian J Endocrinol Metab. 2011 Jul;15(Suppl 2):S117-20
pubmed: 21966647
Gynecol Oncol. 2017 Apr;145(1):88-95
pubmed: 28132722
Thyroid. 2017 Mar;27(3):315-389
pubmed: 28056690
Kobe J Med Sci. 2018 May 28;64(1):E1-E5
pubmed: 30282891